Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction.Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, announced the close of a $103 million Series A financing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
